BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29300083)

  • 1. Identifying Novel Enhancer Elements with CRISPR-Based Screens.
    Klein JC; Chen W; Gasperini M; Shendure J
    ACS Chem Biol; 2018 Feb; 13(2):326-332. PubMed ID: 29300083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing.
    Yoo KH; Hennighausen L; Shin HY
    J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):47-59. PubMed ID: 30291498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9.
    Yan F; Wang W; Zhang J
    Cell Biol Toxicol; 2019 Dec; 35(6):489-492. PubMed ID: 31468291
    [No Abstract]   [Full Text] [Related]  

  • 4. Diverse Class 2 CRISPR-Cas Effector Proteins for Genome Engineering Applications.
    Pyzocha NK; Chen S
    ACS Chem Biol; 2018 Feb; 13(2):347-356. PubMed ID: 29121460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Future of Multiplexed Eukaryotic Genome Engineering.
    Thompson DB; Aboulhouda S; Hysolli E; Smith CJ; Wang S; Castanon O; Church GM
    ACS Chem Biol; 2018 Feb; 13(2):313-325. PubMed ID: 29241002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II-C CRISPR-Cas9 Biology, Mechanism, and Application.
    Mir A; Edraki A; Lee J; Sontheimer EJ
    ACS Chem Biol; 2018 Feb; 13(2):357-365. PubMed ID: 29202216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity.
    Tycko J; Myer VE; Hsu PD
    Mol Cell; 2016 Aug; 63(3):355-70. PubMed ID: 27494557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.
    Montalbano A; Canver MC; Sanjana NE
    Mol Cell; 2017 Oct; 68(1):44-59. PubMed ID: 28985510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-scale CRISPR pooled screens.
    Sanjana NE
    Anal Biochem; 2017 Sep; 532():95-99. PubMed ID: 27261176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
    Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
    Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
    Berkhout B; Gao Z; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis.
    Canver MC; Smith EC; Sher F; Pinello L; Sanjana NE; Shalem O; Chen DD; Schupp PG; Vinjamur DS; Garcia SP; Luc S; Kurita R; Nakamura Y; Fujiwara Y; Maeda T; Yuan GC; Zhang F; Orkin SH; Bauer DE
    Nature; 2015 Nov; 527(7577):192-7. PubMed ID: 26375006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Editing: Insights from Chemical Biology to Support Safe and Transformative Therapeutic Applications.
    Wegrzyn RD; Lee AH; Jenkins AL; Stoddard CD; Cheever AE
    ACS Chem Biol; 2018 Feb; 13(2):333-342. PubMed ID: 28992411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 for Human Genome Engineering and Disease Research.
    Xiong X; Chen M; Lim WA; Zhao D; Qi LS
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():131-54. PubMed ID: 27216776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Disruption Using Chemically Modified CRISPR-Cpf1 RNA.
    McMahon MA; Rahdar M
    Methods Mol Biol; 2021; 2162():49-60. PubMed ID: 32926377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Era of CRISPR/ Cas9 Mediated Plant Genome Editing.
    Khurshid H; Jan SA; Shinwari ZK; Jamal M; Shah SH
    Curr Issues Mol Biol; 2018; 26():47-54. PubMed ID: 28879855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.